Work

A randomized trial of TLR-2 agonist CADI-05 targeting desmocollin-3 for advanced non-small-cell lung cancer

Year: 2016

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw608

Authors: C.P. Belani, B.C. Chakraborty, R.I. Modi, B.M. Khamar

Institutions: Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center, Cadila Pharmaceuticals (India)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Cancer Research Institute, Cycle for Survival, Department of Science and Technology, Ministry of Science and Technology, India

OpenAlex ID: W2549574170

FWCI: 2.707

Cites: 23

Cited by: 52

Related to: 10